The FDA announced Wednesday, March 27, that it is taking action to “modernize” breast cancer screening in the United States by amending the Mammography Quality Standards Act of 1992 with a new proposed rule.
| |||||||||||||||||||||
| |||||||||||||||||||||
- Management
- Imaging
- Technology
- Videos
- Conferences
- Custom Content
- Experience Stories
- Webinars & Videos
|Custom Content - Subscribe
- 40 Under 40 Award
